Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Cellular delivery of peptide nucleic acids and inhibition of human telomerase.

Hamilton SE, Simmons CG, Kathiriya IS, Corey DR.

Chem Biol. 1999 Jun;6(6):343-51.

2.

Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.

Doyle DF, Braasch DA, Simmons CG, Janowski BA, Corey DR.

Biochemistry. 2001 Jan 9;40(1):53-64.

PMID:
11141056
3.

Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells.

Folini M, Bandiera R, Millo E, Gandellini P, Sozzi G, Gasparini P, Longoni N, Binda M, Daidone MG, Berg K, Zaffaroni N.

Cell Prolif. 2007 Dec;40(6):905-20.

PMID:
18021178
4.

Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning.

Hamilton SE, Pitts AE, Katipally RR, Jia X, Rutter JP, Davies BA, Shay JW, Wright WE, Corey DR.

Biochemistry. 1997 Sep 30;36(39):11873-80.

PMID:
9305980
5.

Inhibition of human telomerase activity by peptide nucleic acids.

Norton JC, Piatyszek MA, Wright WE, Shay JW, Corey DR.

Nat Biotechnol. 1996 May;14(5):615-9.

PMID:
9630953
6.

Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.

Liu Y, Braasch DA, Nulf CJ, Corey DR.

Biochemistry. 2004 Feb 24;43(7):1921-7.

PMID:
14967032
7.

Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells.

Shammas MA, Simmons CG, Corey DR, Shmookler Reis RJ.

Oncogene. 1999 Nov 4;18(46):6191-200.

8.

Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation.

Filipovska A, Eccles MR, Smith RA, Murphy MP.

FEBS Lett. 2004 Jan 2;556(1-3):180-6.

9.

Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis.

Pellestor F, Paulasova P, Hamamah S.

Curr Pharm Des. 2008;14(24):2439-44. Review.

PMID:
18781993
10.
11.

Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells.

Villa R, Folini M, Lualdi S, Veronese S, Daidone MG, Zaffaroni N.

FEBS Lett. 2000 May 12;473(2):241-8.

12.
13.

Peptide nucleic acid delivery to human mitochondria.

Chinnery PF, Taylor RW, Diekert K, Lill R, Turnbull DM, Lightowlers RN.

Gene Ther. 1999 Dec;6(12):1919-28. Erratum in: Gene Ther 2000 May;7(9):813.

14.

Inhibition of human telomerase by 2'-O-methyl-RNA.

Pitts AE, Corey DR.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11549-54.

15.

Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.

Kaihatsu K, Huffman KE, Corey DR.

Biochemistry. 2004 Nov 16;43(45):14340-7.

PMID:
15533038
16.

Telomerase as a possible target for anticancer therapy.

Autexier C.

Chem Biol. 1999 Nov;6(11):R299-303. Review.

17.

Recognition of chromosomal DNA by PNAs.

Kaihatsu K, Janowski BA, Corey DR.

Chem Biol. 2004 Jun;11(6):749-58. Review.

18.

Recent advances in the development of peptide nucleic acid as a gene-targeted drug.

Marin VL, Roy S, Armitage BA.

Expert Opin Biol Ther. 2004 Mar;4(3):337-48. Review.

PMID:
15006728
19.

Peptide nucleic acids arrest the growth of gastric cancer cells SGC7901.

Wang K, Zhang QF, Wang XS, Xue YW, Pang D, Fu SB.

Chin Med J (Engl). 2004 Apr;117(4):566-70.

PMID:
15109451
20.

Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.

Gambari R.

Curr Pharm Des. 2001 Nov;7(17):1839-62. Review.

PMID:
11562312
Items per page

Supplemental Content

Support Center